atropine has been researched along with nomifensine in 15 studies
Studies (atropine) | Trials (atropine) | Recent Studies (post-2010) (atropine) | Studies (nomifensine) | Trials (nomifensine) | Recent Studies (post-2010) (nomifensine) |
---|---|---|---|---|---|
26,711 | 1,259 | 1,697 | 1,127 | 111 | 65 |
Protein | Taxonomy | atropine (IC50) | nomifensine (IC50) |
---|---|---|---|
D | Rattus norvegicus (Norway rat) | 2.724 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.631 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.1642 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 8.7096 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 3.115 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.0316 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 2.724 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0781 | |
Transporter | Rattus norvegicus (Norway rat) | 2.7033 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (20.00) | 18.7374 |
1990's | 3 (20.00) | 18.2507 |
2000's | 3 (20.00) | 29.6817 |
2010's | 6 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Damsma, G; de Boer, P; de Vries, JB; Fibiger, HC; Timmerman, W; Westerink, BH | 1 |
Borsini, F; d'Aranno, V; Lecci, A; Mancinelli, A; Meli, A | 1 |
Betti, R; Casanueva, F; Cocchi, D; Motta, T; Müller, EE; Zanardi, P | 1 |
Chang, SS; Cheng, JT | 1 |
2 review(s) available for atropine and nomifensine
Article | Year |
---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
13 other study(ies) available for atropine and nomifensine
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Dopaminergic-cholinergic interactions in the striatum: the critical significance of calcium concentrations in brain microdialysis.
Topics: Acetylcholine; Animals; Apomorphine; Atropine; Calcium; Corpus Striatum; Dextroamphetamine; Dialysis Solutions; Dopamine; Haloperidol; Interneurons; Male; Neostigmine; Nomifensine; Perfusion; Rats; Rats, Inbred Strains; Sodium Chloride; Sulpiride; Tetrahydronaphthalenes; Thiophenes | 1990 |
Cholinergic drug effects on antidepressant-induced behaviour in the forced swimming test.
Topics: Animals; Antidepressive Agents; Atropine; Behavior, Animal; Desipramine; Drug Synergism; Male; Motor Activity; Nomifensine; Pharmaceutical Vehicles; Physical Exertion; Physostigmine; Rats; Scopolamine; Swimming | 1988 |
A role for dopamine in growth hormone regulation in the dog.
Topics: Animals; Apomorphine; Atropine; Benzimidazoles; Dogs; Domperidone; Dopamine; Female; Growth Hormone; Haloperidol; Isoquinolines; Kinetics; Male; Nomifensine; Phentolamine; Pimozide; Piperidines | 1981 |
Inhibitory effect of octopamine on the release of endogenous acetylcholine from isolated myenteric synaptosomes of guinea-pig.
Topics: Acetylcholine; Adrenergic alpha-Antagonists; Animals; Atropine; Calcium; Dopamine Agents; Female; Guanethidine; Guinea Pigs; Ileum; In Vitro Techniques; Male; Myenteric Plexus; Naloxone; Nomifensine; Octopamine; Propranolol; Substance P; Synaptosomes | 1993 |